Premium
Medications for substance use disorders lower risk of crime, suicidal behavior
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30367
Subject(s) - psychiatry , medicine , cohort , substance use , acamprosate , suicidal behavior , population , poison control , suicide prevention , opioid , medical emergency , naltrexone , environmental health , receptor
A population cohort study conducted in Sweden has found that most of the medication treatments approved for alcohol and opioid use disorders appear to reduce the risk of adverse outcomes such as crime and suicidality. Only acamprosate for alcohol dependence was not significantly associated with any of the outcomes studied, the researchers reported. Study results were published online Aug. 2 in the American Journal of Psychiatry .